GE HealthCare’s MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes
22 4월 2024 - 8:07PM
Business Wire
- Collaboration has always been important in the healthcare
industry, but in this era of digital health, teamwork across
institutions has become essential
- Enhancing Elekta’s radiation therapy offerings with GE
HealthCare’s MIM Software medical imaging management solutions will
help drive greater benefits for global healthcare systems
- This new collaboration complements GE HealthCare and Elekta’s
existing global commercial collaboration agreement, which enables
the two companies to provide hospitals and cancer patients a
comprehensive radiation therapy offering across imaging and
treatment
Weeks after closing its acquisition of MIM Software – a global
provider of medical imaging analysis and artificial intelligence
(AI) solutions – GE HealthCare is proud to announce the expansion
of its relationship with Elekta (EKTA-B.ST), a leader in precision
radiation oncology. Together, the companies aim to accelerate
innovation in software solutions that will help improve workflows,
increase throughput, and enhance user experience for clinicians,
while also enabling greater precision in treatment and less time
spent at the hospital for patients.
Nearly two-thirds of all cancer patients receive radiation
therapy (RT), a type of treatment that can either be given alone or
in combination with surgery and/or chemotherapy.i However, it can
take weeks for a patient to go from a cancer diagnosis to
treatment, in part due to a persistent lack of interoperability and
automation – a delay that may have a significant impact on patient
outcomes.ii Furthermore, therapy advancements – such as
hypofractionation, adaptive therapy, and more – may require
precise, multi-modality imaging supported by advanced post
processing.
“Our decision to join GE HealthCare was driven by a ‘shared
vision of maximizing impact’ and our motivation for this
collaboration with Elekta is no different,” explains Andy Nelson,
CEO of MIM Software, GE HealthCare. “For decades, we have engaged
directly with clinicians to understand their needs and bridge the
divide by building solutions that streamline their clinical
workflows and reduce treatment delays for patients. With the
evolution of treatment planning software, we stand to make an
impact on clinicians and patients worldwide. Now, we are excited to
extend the reach of these efforts by boosting Elekta’s offerings
with our vendor-agnostic solutions.”
GE HealthCare’s MIM Software portfolio with Elekta’s treatment
planning software offerings will enable advanced and innovative
oncology treatment planning in the delivery of radiation therapy.
The collaboration is expected to drive innovation within treatment
planning, harnessing MIM Software and Elekta’s respective strengths
in regional markets to make solutions available globally.
“While this is an exciting step for both companies it’s a
significant development for radiation therapy clinics and their
patients,” adds Maurits Wolleswinkel, Elekta’s President Linac and
Software Solutions. “This is a natural expansion of our portfolio,
combining our innovative dose planning capabilities with MIM
Software's proven track record of physician-preferred tools .
Clinically, it means delivering on improved automation and adaptive
therapy planning, as well as greater speed and accuracy. And our
vendor-agnostic philosophy ensures that all radiation therapy
providers stand to gain from this collaboration.”
Today’s announcement complements GE HealthCare and Elekta’s
existing global collaboration agreement, which enables the two
companies to provide hospitals with a comprehensive offering across
imaging and treatment for cancer patients requiring radiation
therapy.
“GE HealthCare and MIM Software have a long history of
collaborating with healthcare systems, research institutions, and
our fellow medical software and technology providers to meet the
most pressing needs of our customers and their patients,” shares
Ben Newton, General Manager, Oncology, GE HealthCare. “Today’s
announcement is another demonstration of how MIM Software solutions
enables advanced visualization and treatment planning offerings. We
expect many more examples of this to come.”
GE HealthCare unites cancer screening with precision image
guided therapy through an ecosystem of devices and digital
solutions powered by AI to create seamless coordination and advance
the patient journey throughout the entire pathway from early
detection to follow up and assessment. This portfolio of oncology
solutions – including Intelligent RT (iRT), Maestro, Discovery RT,
and more – in combination with the company’s expertise and
collaborations help drive optimization and transform personalized
cancer care for improved outcomes.
For more information on GE HealthCare and MIM Software’s
radiation therapy solutions, please visit GEHealthCare.com and
MIMSoftware.com. GE HealthCare will also showcase MIM Software
solutions at the following global conferences:
- European Society for Radiotherapy and Oncology (ESTRO) in
Glasgow, United Kingdom;
- American Society of Clinical Oncology (ASCO) in Chicago,
Illinois; and
- Society of Nuclear Medicine and Molecular Imaging (SNMMI) in
Toronto, Canada.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 125 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Ultrasound, Patient Care Solutions,
and Pharmaceutical Diagnostics businesses help improve patient care
from diagnosis, to therapy, to monitoring. We are a $19.6 billion
business with approximately 51,000 colleagues working to create a
world where healthcare has no limits.
Follow us on LinkedIn, X (formerly Twitter), and Insights for
the latest news, or visit our website https://www.gehealthcare.com/
for more information.
_________________________________ i ASTRO Legislative
Priorities. Available at
https://www.astro.org/uploadedFiles/Main_Site/Meetings_and_Events/2015_Advocacy_Day/Advocacy%20Day%20-%20iPad%20-%20(Linked).pdf.
Accessed April 2023. ii Li E, Clarke J, Ashrafian H, Darzi A, Neves
AL. The Impact of Electronic Health Record Interoperability on
Safety and Quality of Care in High-Income Countries: Systematic
Review. J Med Internet Res. 2022 Sep 15;24(9):e38144. doi:
10.2196/38144. PMID: 36107486; PMCID: PMC9523524.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523524/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240422400181/en/
Margaret Steinhafel Global Communications Director, Molecular
Imaging & Computed Tomography GE HealthCare +1 608 381 8829
Margaret.Steinhafel@gehealthcare.com
GE HealthCare Technologies (NASDAQ:GEHC)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
GE HealthCare Technologies (NASDAQ:GEHC)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024